Status:
COMPLETED
Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot Study
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Acute Asthma
Eligibility:
All Genders
5-17 years
Phase:
NA
Brief Summary
Our overall objective is to model a pediatric Acute Asthma Clinical Decision Rule (ADR) for personalized medicine by identification of treatment-response phenotypes that are important determinants of ...
Detailed Description
The objective of this study is to determine the feasibility of this approach by enrolling a pilot cohort of 16 participants in this DBRCT of 4 different albuterol treatment regimens, 2 of which will u...
Eligibility Criteria
Inclusion
- Doctor diagnosed asthma
- Acute asthma exacerbation
- Treatment with systemic corticosteroids and nebulized albuterol
- Ages 5 to 17 years
Exclusion
- Other acute or chronic lung disease
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01196377
Start Date
September 1 2010
End Date
October 1 2010
Last Update
September 29 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.